John Crowley (biotech executive)
John Francis Crowley ( born April 7, 1967 in Englewood, Bergen County, New Jersey) is an American lawyer, officer, biotech managers and entrepreneurs. He is the founder of several biotechnology companies that deal with the cure of genetic diseases.
Career
John Francis Crowley graduated 1985 at the Bergen Catholic High School. Then he attended the U.S. Naval Academy in Annapolis (Maryland ), between 1986 and 1987. Then he made a Bachelor of Science in Foreign Service ( BSFS ) at Georgetown University. Crowley went from 1989 to the University of Notre Dame Law School, where he received his Juris Doctor in 1992. During this time he married in 1990 Aileen Holleran. After graduating, he began as a process staff in the Health Care Practice Group, which was founded in Indianapolis law firm of Bingham Summers Welsh & Spilman. He graduated in 1997 from Harvard Business School with an MBA and then worked for a consulting firm in San Francisco.
In the two youngest of his children, Megan and Patrick, 1998, a devastating neuromuscular genetic disease, glycogen storage disease type II, also called Pompe disease, diagnosed. Due to the deteriorating health status of children, the family moved to Princeton (New Jersey), to be near doctors who specialize in this hereditary disease. Crowley worked for Bristol -Myers Squibb, where he held several management positions over time. Frustrated by the slow progress of research in Pompe disease, Crowley left in March 2000, Bristol -Myers Squibb. He took a position as CEO at Novazyme, a start -up company in the biotech sector in Oklahoma City, on which was a leader in the exploration of a new experimental treatment for this genetic disease.
As an article on Crowley Novazyme was founded in 2001 by Genzyme Corporation, the third largest biotech company in the world acquired. Under the leadership of Genzyme Megan and Patrick Crowley could be started with an enzyme replacement therapy in January 2003. John Crowley believed that this life of his children would be saved. The children are today still dependent on ventilators. The acquisition of Novazyme by Genzyme and Crowley's fight against Pompe disease were in the Harvard Business School Case Study, Novazyme: A Father's Love documented.
Crowley joined Orexigen Therapeutics, where he was president and CEO in 2003. After that, he was at Amicus Therapeutics, based in Cranbury (New Jersey ), where he was also appointed in January 2005 as President and CEO. He also served in the U.S. Navy Reserve as an intelligence officer. He undertook in 2007 a six-month mission to the Center for Naval Intelligence in Virginia. Crowley is currently a Navy reserve unit of the United States Special Operations Command assigned.
John Francis Crowley is the carrier of an honorary doctorate from Neumann University in Aston (Pennsylvania ), where he also held the closing speech. He is also a member of the Henry Crown Program at the Aspen Institute.
Books and film
The Pulitzer Prize winner Geeta Anand wrote in the Wall Street Journal published an article about Crowley. Subsequently, she deepened her work and eventually brought out a book in 2006.
Inspired by Anand's book and Crowley's family acquired Harrison Ford and Double Feature Films, the film rights to the work. In April 2009, CBS began the film with the shooting. The film, Extraordinary Measures, came on 22 January 2010 nationwide in theaters. The director had Tom Vaughan, and were among the film Cast Brendan Fraser ( John Crowley), Keri Russell ( Aileen Crowley) and the executive producer Harrison Ford, who played the fictitious " Dr. Robert Stonehill ". Dr. Stonehill originated from a variety of scientists and researchers with whom Crowley had worked with over the years. John Crowley wrote a joint book with his wife and Ken Kurson. It was published by the New Market Press in January 2010, simultaneously with the film's release.
Political action
In spring 2008, Crowley was often called in New Jersey as a potential candidate for the Republican nomination for the U.S. Senate, where he was supposed to start after successful primaries against incumbent Democrat Frank Lautenberg. Although Crowley refused to start, reports showed on April 4, 2008, that he would post the race when he took to the closing date of April 7. The speculation about his nomination ended on April 6, finally, as Crowley once again announced that he would not run for the U.S. Senate.
Crowley served as Honorary Chairman of Building the New Majority, a Continuing Political Committee, works. He was also in numerous cases of public policy ( public policy ) involved, in particular rare hereditary diseases and health defects. On July 22, he stopped in front of hundreds of Congress workers in the Cannon House Caucus Room a speech on " Biotechnology Medicine and securing patient safety ."